Single-cell sequencing reveals 25 subpopulations of myeloid cells, a poorly understood family of immune cells, in lung cancer tumors. Many subpopulations are similar across humans and mice, supporting the use of mouse models in immunotherapy research. Findings set stage to assess myeloid cells as targets for new or improved immunotherapies.